Haemodialysis vascular catheter-related blood stream infection: Organism types and clinical outcomes.


Journal

Nephrology (Carlton, Vic.)
ISSN: 1440-1797
Titre abrégé: Nephrology (Carlton)
Pays: Australia
ID NLM: 9615568

Informations de publication

Date de publication:
Apr 2023
Historique:
revised: 15 12 2022
received: 17 10 2022
accepted: 27 01 2023
pubmed: 31 1 2023
medline: 25 3 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

Catheter-related bloodstream infection (CRBI) is an important complication of catheter use for haemodialysis, but it remains unclear whether clinical outcomes following CRBI are influenced by organism type. This study aims to compare clinical outcomes following CRBI from Gram-positive and non-Gram-positive organisms. This was a retrospective cohort study of patients with kidney failure receiving haemodialysis (HD) via vascular catheters who had a documented episode of CRBI in Western Australia between 2005 and 2018. The associations between organism type, likelihood of hospitalization, catheter removal and death from CRBI were examined using adjusted logistic regression models. There were 111 episodes of CRBI in 99 patients (6.1 episodes per 1000-catheter-days at risk). Of the study cohort, 53 (48%) were male and 38 (34%) identified as Aboriginal or Torres Strait Islander. Gram-positive organisms were identified in 73 (66%) CRBI episodes, most commonly Staphylococcus aureus. Of those with non-Gram-positive CRBI, 9 (24%) were attributed to Pseudomonas aeruginosa. One-hundred and two (92%) episodes of CRBI required hospitalization and 15 (13%) patients died from CRBI. Compared with non-Gram-positive CRBI, Gram-positive CRBI was associated with an increased risk of hospitalization and catheter removal, with adjusted odds ratio of 9.34 (95% CI 1.28-68.03) and 3.47 (95% CI 1.25-9.67), respectively. There was no association between organism type and death from CRBI. Staphylococcus aureus remains the most common organism causing CRBI in HD patients. CRBI is associated with substantial morbidity, particularly CRBI attributed to Gram-positive organisms.

Identifiants

pubmed: 36715242
doi: 10.1111/nep.14147
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-253

Informations de copyright

© 2023 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.

Références

Martin K, Lorenzo YSP, Leung PYM, et al. Clinical outcomes and risk factors for tunneled hemodialysis catheter-related bloodstream infections. Open Forum Infect Dis. 2020;7(6):ofaa117.
Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis. 2005;46(3):501-508.
Nelveg-Kristensen KE, Laier GH, Heaf JG. Risk of death after first-time blood stream infection in incident dialysis patients with specific consideration on vascular access and comorbidity. BMC Infect Dis. 2018;18(1):688.
Tokars JI, Light P, Anderson J, et al. A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis. 2001;37(6):1232-1240.
Farrington CA, Allon M. Management of the Hemodialysis Patient with catheter-related bloodstream infection. Clin J Am Soc Nephrol. 2019;14(4):611-613.
Farrington CA, Allon M. Complications of hemodialysis catheter bloodstream infections: impact of infecting organism. Am J Nephrol. 2019;50(2):126-132.
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318-1322.
Paharik AE, Horswill AR. The staphylococcal biofilm: adhesins, regulation, and host response. Microbiol Spectr. 2016;4(2). https://doi.org/10.1128/microbiolspec.VMBF-0022-2015.
Taupin D, Karchmer AW, Davis RB, LaSalvia MT. Uncomplicated Staphylococcus aureus bacteremia treatment duration and outcomes at an Academic Medical Center. Open Forum Infect Dis. 2020;7(10):ofaa457.
Turnidge JD, Kotsanas D, Munckhof W, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust. 2009;191(7):368-373.
Smyth B, Kotwal S, Gallagher M, Gray NA, Polkinghorne K, Project RP. Dialysis catheter management practices in Australia and New Zealand. Nephrology (Carlton). 2019;24(8):827-834.

Auteurs

Jessica Phillips (J)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.

Doris T Chan (DT)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.

Aron Chakera (A)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.

Ramyasuda Swaminathan (R)

Department of Renal Medicine, Fiona Stanley Hospital, Perth, Australia.

Khalil Patankar (K)

Department of Renal Medicine, Royal Perth Hospital, Perth, Australia.

Neil Boudville (N)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Medical School, University of Western Australia, Perth, Australia.

Wai H Lim (WH)

Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Medical School, University of Western Australia, Perth, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH